Aleksey Oparin, Anton Kudriavtsev, Anatoliy Oparin


Diabetes mellitus is one of the most serious problems of the clinical medicine. This is determined by the fact that it is followed by multisystemic affects, as well as complications on the side of other organs and systems, among which a special place is occupied by gastroesophageal reflux disease. As for the combination and mutual influence of diabetes mellitus and gastroesophageal reflux disease, this issue has not been studied yet, the data of modern literature are not complete and quite contradictory.

The aim of the study: to investigate the state of the factors of aggression and protection of the oesophageal mucosa in patients with diabetes mellitus type II with concomitant gastroesophageal reflux disease without associated pathology.

Method. There were two groups of patients under observation. The first group included 45 patients with diabetes mellitus type II with concomitant gastroesophageal reflux disease (26 men and 19 women). The second group included 38 patients with gastroesophageal reflux disease without associated pathology – 20 men and 18 women. By sex, age, body weight, Helicobacter pylori infection, smoking and alcohol consumption, both groups were comparable. The surveillance program included determining the compensation ratio of carbohydrate metabolism and the state of the factor. The antioxidant protection factor was assessed by the level of catalase activity in the blood serum, as well as by the diameter of the celiac trunk and the blood flow velocity in it. Statistical processing of the obtained data was carried out with the aid of the program WINDOWS STATISTIKA 6.0. For all types of analysis, differences were considered statistically significant with p<0.05.

Results. During the study, we found that in patients with diabetes mellitus type II with concomitant gastroesophageal reflux disease, as well as in patients with gastroesophageal reflux disease without associated pathology, the level of pH-metry was reduced, but with varying measures of confidence. At the same time, we found that patients with GERD without associated pathology had a decrease in the blood flow velocity in the celiac trunk. Concurrently, we ascertained that the decrease in the blood flow velocity in patients of both groups reduced the diameter of the celiac trunk.

Conclusions. In patients with diabetes mellitus type II, concomitant gastroesophageal reflux disease has a subtle clinical presentation that is affected by a significant decline in mucosal sealing protection factors. In patients with GERD without associated pathology, typical clinical manifestations, accompanied by inflammation, acid regurgitation and dyspepsia, are more vivid.


diabetes mellitus type II; gastroesophageal reflux disease; level of pH-metry; factors of aggression and protection; oesophageal mucosa

Full Text:



Becker, C., Meier, C. R., Jick, S. S., Bodmer, M. (2013). Case–control analysis on metformin and cancer of the esophagus. Cancer Causes & Control, 24 (10), 1763–1770. doi:

Kahrilas, P. J., Howden, C. W., Wernersson, B., Denison, H., Nuevo, J., Gisbert, J. P. (2013). Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study. Alimentary Pharmacology & Therapeutics, 37 (10), 1005–1010. doi:

Promberger, R., Lenglinger, J., Riedl, O., Seebacher, G., Eilenberg, W. H., Ott, J. et. al. (2013). Gastro-oesophageal reflux disease in type 2 diabetics: symptom load and pathophysiologic aspects – a retro-pro study. BMC Gastroenterology, 13 (1). doi:

Rubenstein, J. H., Chen, J. W. (2014). Epidemiology of Gastroesophageal Reflux Disease. Gastroenterology Clinics of North America, 43 (1), 1–14. doi:

Association between tea consumption and gastroesophageal reflux disease. (2019). Medicine, 98 (10), e14915. doi:

Walker, M. M., Powell, N., Talley, N. J. (2014). Atopy and the gastrointestinal tract – a review of a common association in unexplained gastrointestinal disease. Expert Review of Gastroenterology & Hepatology, 8 (3), 289–299. doi:

Boeckxstaens, G., El-Serag, H. B., Smout, A. J. P. M., Kahrilas, P. J. (2014). Symptomatic reflux disease: the present, the past and the future. Gut, 63 (7), 1185–1193. doi:

Hirata, A., Kishida, K., Nakatsuji, H., Inoue, K., Hiuge-Shimizu, A., Funahashi, T., Shimomura, I. (2012). High prevalence of gastroesophageal reflux symptoms in type 2 diabetics with hypoadiponectinemia and metabolic syndrome. Nutrition & Metabolism, 9 (1), 4. doi:

Agrawal, S., Patel, P., Agrawal, A., Makhijani, N., Markert, R., Deidrich, W. (2014). Metformin Use and the Risk of Esophageal Cancer in Barrett Esophagus. Southern Medical Journal, 107 (12), 774–779. doi:

Kahrilas, P. J., McColl, K., Fox, M., OʼRourke, L., Sifrim, D., Smout, A. J. P. M., Boeckxstaens, G. (2013). The Acid Pocket: A Target for Treatment in Reflux Disease? American Journal of Gastroenterology, 108 (7), 1058–1064. doi:

Katz, P. O., Gerson, L. B., Vela, M. F. (2013). Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology, 108 (3), 308–328. doi:

Krishnan, B. (2013). Gastrointestinal complications of diabetes mellitus. World Journal of Diabetes, 4 (3), 51. doi:

Lee, D., Lee, K. J., Kim, K. M., Lim, S. K. (2013). Prevalence of asymptomatic erosive esophagitis and factors associated with symptom presentation of erosive esophagitis. Scandinavian Journal of Gastroenterology, 48 (8), 906–912. doi:

Lim, C.-H., Choi, M.-G., Baeg, M. K., Moon, S. J., Kim, J. S., Cho, Y. K. et. al. (2014). Symptom Characteristics and Psychosomatic Profiles in Different Spectrum of Gastroesophageal Reflux Disease. Gut and Liver, 8 (2), 165–169. doi:

Lundell, L. (2014). Borderline Indications and Selection of Gastroesophageal Reflux Disease Patients: ‘Is Surgery Better than Medical Therapy? Digestive Diseases, 32 (1-2), 152–155. doi:

Natalini, J., Palit, A., Sankineni, A., Friedenberg, F. K. (2014). Diabetes mellitus is an independent risk for gastroesophageal reflux disease among urban African Americans. Diseases of the Esophagus, 28 (5), 405–411. doi:

Oparin, A. A., Beziazychna, N. V. (2016). Implementation mechanisms of psychosomatic disorders in gastroesophageal reflux disease with concomitant chronic obstructive pulmonary disease. Med Jad, 46 (1-2), 125–132.

Oparin, A., Kornienko, D. (2017). Formation process of motor-evacuatory disorders in patients with gastroesophageal reflux disease and concomitant obesity. Gastroenterologie a Hepatologie, 71 (2), 145–149. doi:

Shekhovtsova, Y., Zhuravlyova, L. (2015). Exocrine pancreatic function in patients with type 2 diabetes mellitus with different phenotype. Pancreatology, 15 (3), S72–S73. doi:

Stevens, J. E., Jones, K. L., Rayner, C. K., Horowitz, M. (2013). Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives. Expert Opinion on Pharmacotherapy, 14 (9), 1171–1186. doi:

Sun, X.-M. (2015). Association between diabetes mellitus and gastroesophageal reflux disease: A meta-analysis. World Journal of Gastroenterology, 21 (10), 3085. doi:



  • There are currently no refbacks.

Copyright (c) 2020 Aleksey Oparin, Anton Kudriavtsev, Anatoliy Oparin

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)